GGrantIndex
Sort

10,829 grants matching car t

Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia

$311,223
Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA

Placental P-gp/BCRP in fetal drug exposure and regulation by hormones/xenobiotic

$311,186
Qingcheng Mao · University Of Washington · P01 · FY2014 · DA

Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients

$311,063
Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA

Cardiac Physiology and Imaging Core for Mouse in Vivo

$310,718
Kirk L Peterson · University Of California, San Diego · P01 · FY2009 · HL

Adhesion Molecules of the Intercalated Disc in Cardiomyopathy

$310,717
Kirk U Knowlton · University Of California, San Diego · P01 · FY2011 · HL

Adhesion Molecules of the Intercalated Disc in Cardiomyopathy

$310,717
Kirk U Knowlton · University Of California, San Diego · P01 · FY2009 · HL

Adhesion Molecules of the Intercalated Disc in Cardiomyopathy

$310,717
Kirk U Knowlton · University Of California, San Diego · P01 · FY2010 · HL

RUI: Probing adsorbate interactions in metal-organic frameworks using site selective spectroscopy

$310,567
Stephen A Fitzgerald · Oberlin College · · FY2017 · MPS

Resource for Molecular Imaging Agents in Precision Medicine

$310,425
Martin G Pomper · Johns Hopkins University · P41 · FY2019 · EB

Project 4: Enhancing the Efficacy of Chimeric Antigen Receptor Therapy for B-ALL and DLBCL

$310,192
Crystal Mackall · Stanford University · P01 · FY2022 · CA

GOALI: Modeling, Evaluation, and Control of Tire Blowout for Automated and Partially Automated Vehicles

$310,000
Yan Chen · Arizona State University · · FY2021 · ENG

Development of companion diagnostics for dasatinib-based personalized therapy for T-ALL

$310,000
Anton Iliuk · Tymora Analytical Operations, Llc · R43 · FY2021 · CA

Collaborative Research: RI: Medium: Robust Perception through End-User Adaptation

$310,000
Wei-Lun Chao · Ohio State University, The · · FY2021 · CSE

Time Restricted Eating As a Viable Alternative to Caloric Restriction for Treating Hyperglycemia in a Population with Type 2 (T2DM) diabetes

$310,000
Lisa Senye Chow · University Of Minnesota · R01 · FY2022 · DK

Collaborative Research: Towards Attack-Resilient Vision-Guided Unmanned Aerial Vehicles: An Observability Analysis Approach

$309,811
Hamidreza Jafarnejadsani · Stevens Institute Of Technology · · FY2022 · ENG

Perilipin and cellular triacylglycerol metabolism

$309,773
Dawn L Brasaemle · Rutgers, The State Univ Of N.J. · R01 · FY2011 · DK

Multimodal multiphoton imaging of nervous system ex vivo and in vivo

$309,719
Ji-Xin Cheng · Purdue University · R01 · FY2009 · EB

Rapid, single-step precision engineering and pre-clinical evaluation of chimeric antigen receptor Regulatory T cells for Type 1 diabetes

$309,636
Ryan Pawell · Indee, Inc · R43 · FY2022 · DK

Decision Making Among Older Adults: "Firearm Retirement"

$309,621
Marian Elizabeth Betz · University Of Colorado Denver · R01 · FY2020 · AG

Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors

$309,514
John H Sampson · Duke University · P50 · FY2016 · CA

What fuels CAR T-cell serial killing

$309,507
Roderick O'Connor · University Of Pennsylvania · R01 · FY2025 · CA

SCH: INT: AURA - Connecting Audio and Radio Sensing Systems to lmprove Care at Home

$309,026
Shahriar Nirjon · Univ Of North Carolina Chapel Hill · R01 · FY2021 · LM

Chimeric T Cell for Therpay of Hodgkin Disease

$308,958
Barbara Savoldo · Baylor College Of Medicine · R01 · FY2011 · CA

Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.

$308,958
Patricia Yotnda · Baylor College Of Medicine · R01 · FY2012 · CA

Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.

$308,958
Patricia Yotnda · Baylor College Of Medicine · R01 · FY2011 · CA